PinnyPeptide

GHK-Cu vs Melanotan II

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

GHK-Cu

Cosmetic

Copper-binding tripeptide with potent wound-healing, skin-remodeling, and gene-regulatory properties.

Peptide B

Melanotan II

Cosmetic

Synthetic melanocortin peptide with tanning, appetite-suppressive, and sexual function effects.

Typical vial

50 mg

Typical dose

200-500 mcg

Half-life

~30-60 minutes (plasma)

FDA status

Not FDA approved as a drug. Widely used as a cosmetic ingred…

Typical vial

10 mg

Typical dose

250-1000 mcg

Half-life

~33 minutes

FDA status

Not FDA approved. The FDA has issued warnings against the us…

GHK-Cu effects

  • Stimulates collagen and elastin synthesis for skin rejuvenation
  • Promotes wound healing and tissue remodeling
  • Enhances angiogenesis and blood vessel formation
  • Modulates expression of over 4,000 genes involved in tissue repair
  • Provides antioxidant defense via superoxide dismutase activation
  • Reduces fine lines, wrinkles, and photodamage

Melanotan II effects

  • Stimulates melanin production for UV-independent tanning
  • Increases sexual arousal and libido (both sexes)
  • Reduces appetite and food intake
  • May promote fat loss through melanocortin receptor activation
  • Enhances erectile function in men

GHK-Cu side effects

  • Mild skin irritation with topical use (uncommon)
  • Injection site discomfort with subcutaneous administration
  • Uncommon metallic taste
  • Rare contact sensitivity in predisposed individuals

Melanotan II side effects

  • Nausea (very common, especially at initial doses)
  • Facial flushing and warmth
  • Spontaneous erections in men
  • Darkening of existing moles and nevi
  • Headache
  • Potential risk of stimulating melanocyte proliferation — theoretical concern for melanoma in predisposed individuals

GHK-Cu dosing ranges

Skin rejuvenation (topical)

1-2% concentration · Once or twice daily · Ongoing

Systemic tissue support (SubQ)

200-500 mcg · Once daily · 4-6 weeks

Wound healing support (SubQ)

200-500 mcg · Once daily near wound site · 2-4 weeks

Melanotan II dosing ranges

Tanning (loading phase)

250-500 mcg · Once daily · 2-3 weeks

Tanning (maintenance)

250-500 mcg · Once or twice weekly · Ongoing with UV exposure

Sexual function enhancement

500-1000 mcg · As needed, 1-2 hours before activity · As needed

GHK-Cu vs Melanotan II — common questions

What is the difference between GHK-Cu and Melanotan II?

GHK-Cu: Copper-binding tripeptide with potent wound-healing, skin-remodeling, and gene-regulatory properties. Typical dose 200-500 mcg. Melanotan II: Synthetic melanocortin peptide with tanning, appetite-suppressive, and sexual function effects. Typical dose 250-1000 mcg. Both fall under the Cosmetic category.

Can you stack GHK-Cu and Melanotan II?

Stacking GHK-Cu with Melanotan II is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, GHK-Cu or Melanotan II?

GHK-Cu is typically dosed: Once or twice daily for Skin rejuvenation (topical); Once daily for Systemic tissue support (SubQ); Once daily near wound site for Wound healing support (SubQ). Melanotan II is typically dosed: Once daily for Tanning (loading phase); Once or twice weekly for Tanning (maintenance); As needed, 1-2 hours before activity for Sexual function enhancement.

Are GHK-Cu and Melanotan II FDA approved?

GHK-Cu: Not FDA approved as a drug. Widely used as a cosmetic ingredient without requiring drug approval for topical formulations. Melanotan II: Not FDA approved. The FDA has issued warnings against the use of Melanotan II, citing it as an unregulated and potentially dangerous product. The derivative PT-141 (bremelanotide/Vyleesi) was approved for sexual dysfunction but Melanotan II itself was not pursued for approval.

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free